Red Cedar Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$291K Hold
1,649
0.18% 54
2022
Q3
$269K Sell
1,649
-9
-0.5% -$1.52K 0.19% 55
2022
Q2
$294K Hold
1,658
0.2% 55
2022
Q1
$294K Hold
1,658
0.18% 56
2021
Q4
$284K Hold
1,658
0.16% 58
2021
Q3
$268K Hold
1,658
0.16% 56
2021
Q2
$273K Hold
1,658
0.17% 60
2021
Q1
$272K Hold
1,658
0.18% 57
2020
Q4
$261K Sell
1,658
-400
-19% -$59K 0.19% 56
2020
Q3
$306K Hold
2,058
0.27% 49
2020
Q2
$289K Hold
2,058
0.26% 48
2020
Q1
$270K Hold
2,058
0.27% 47
2019
Q4
$300K Hold
2,058
0.23% 51
2019
Q3
$266K Hold
2,058
0.22% 52
2019
Q2
$287K Hold
2,058
0.24% 51
2019
Q1
$288K Hold
2,058
0.25% 51
2018
Q4
$266K Hold
2,058
0.26% 52
2018
Q3
$284K Hold
2,058
0.25% 50
2018
Q2
$250K Hold
2,058
0.23% 55
2018
Q1
$263K Hold
2,058
0.24% 54
2017
Q4
$288K Buy
+2,058
New +$287K 0.24% 52

Other funds holding JNJ

Red Cedar Capital's JNJ Position: Q4 2022 in Review

Red Cedar Capital held its Johnson & Johnson (JNJ) position steady in Q4 2022 at 1,649 shares worth $291K. The position accounts for 0.18% of the portfolio, ranked #54.

Red Cedar Capital first reported a position in JNJ in Q4 2017 and has held it in 21 quarters since. The position peaked at $306K in Q3 2020. 3,788 funds tracked by Wall St. Rank hold JNJ as of Q4 2022.

  • Red Cedar Capital held 1,649 shares of Johnson & Johnson worth $291K as of Q4 2022.
  • Red Cedar Capital left its Johnson & Johnson share count unchanged in Q4 2022.
  • Johnson & Johnson made up 0.18% of Red Cedar Capital's portfolio in Q4 2022, its #54 holding.
  • Red Cedar Capital first reported a position in Johnson & Johnson in Q4 2017 and has held it in 21 quarters since.
  • Red Cedar Capital's Johnson & Johnson position peaked at $306K in Q3 2020.
  • 3,788 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2022.

Based on Red Cedar Capital's 13F filing for Q4 2022, filed 6 Feb 2023.